Medicus Pharma Ltd. (MDCXW) stock
MDCXWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCX
$0.21+0.00 (0.00%)
Close on Oct 30, 2026Market cap $118.78MP/E –Yield –
Medicus Pharma operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Medicus Pharma's operating income for the twelve months ending Jun 30, 2026 was -$27.87M. For fiscal 2025 it was -$34.36M.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$34.36M | – |
| FY2024 | Dec 31, 2024 | -$11.18M | – |
| FY2023 | Dec 31, 2023 | -$4.73M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.48M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.60M | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.79M | – |
| Q3 FY2025 | Sep 30, 2025 | -$15 | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.02M | – |
| Q1 FY2025 | Mar 31, 2025 | -$5.13M | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.59M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.33M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.55M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.71M | – |